Dispatch Biotherapeutics Stock
HealthTechLooking to sell Dispatch Biotherapeutics stock or options?
Dispatch Biotherapeutics is focused on creating cancer treatments that leverage the power of the immune system. The company is dedicated to developing therapies aimed at eradicating cancer tumors while preventing their recurrence, thereby offering patients more effective cancer treatment options.
Investors Include:
ARCH Venture Partners, Penn Center for Innovation.